Загрузка...
A highly sensitive LC-MS/MS method to determine novel Bruton's tyrosine kinase inhibitor spebrutinib: application to metabolic stability evaluation
Spebrutinib (SBT) is a Bruton's tyrosine kinase inhibitor. SBT is currently in phase II and phase I clinical trials for the management of rheumatoid arthritis and chronic lymphocytic leukaemia, respectively. We developed and validated a liquid chromatography tandem mass spectrometry analytical...
Сохранить в:
| Опубликовано в: : | R Soc Open Sci |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Royal Society
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599791/ https://ncbi.nlm.nih.gov/pubmed/31312501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsos.190434 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|